FDA
-
-
-
-
-
-
-
Geron appoints Timothy Williams as chief legal officer
-
-
-
-
-
-
-
Geron plans workforce reduction of about one-third amid restructuring
-
-
-
-
-
-
-
Geron Corporation Announces Executive Leadership Transitions and Appointments
-
-
-
-
-
-
-
Geron Announces Presentations at ASCO and EHA Underscoring RYTELO® (imetelstat) Efficacy and Safety Across Range of LR-MDS Patients, and Showcasing Momentum of Myelofibrosis Program
-
-
-
-
-
-
-
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Geron Corporation and Certain Officers – GERN
-
-
-
-
-
-
-
Geron Announces European Commission Approval of RYTELO® (imetelstat), a First-in-Class Telomerase Inhibitor, for the Treatment of Adults With Transfusion-Dependent Anemia Due to Lower-Risk MDS
-
-
-
-
-
-
-
Geron Announces Phase 1 Findings from Two-Part IMproveMF Study Presented at ASH Suggesting Tolerability of RYTELO™ (imetelstat) in Combination with Ruxolitinib as Frontline Therapy in Patients with
-
335,520 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


